Related Experiment Video
Updated: Mar 17, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Classification of Non-Small Cell Lung Cancer Using Significance Analysis of Microarray-Gene Set Reduction Algorithm
Lei Zhang1, Linlin Wang2, Bochuan Du2
1School of Life Science, Jilin University, 2699 Qianjin Street, Changchun, Jilin 130012, China; Department of Neurology, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun, Jilin 130041, China.
Significance analysis of microarray-gene set reduction (SAMGSR) effectively identifies gene expression signatures for distinguishing non-small cell lung cancer (NSCLC) subtypes. This method shows comparable or superior performance to other algorithms for feature selection.
Area of Science:
- Oncology
- Bioinformatics
- Genomics
Background:
- Non-small cell lung cancer (NSCLC) comprises major subtypes: adenocarcinoma (AC) and squamous cell carcinoma (SCC).
- AC and SCC are distinct diseases with differing origins, lung locations, and growth patterns.
- Gene expression signatures are valuable for differentiating AC and SCC.
Purpose of the Study:
- To evaluate the Significance Analysis of Microarray-Gene Set Reduction (SAMGSR) for feature selection in NSCLC.
- To construct gene expression signatures for distinguishing AC and SCC subtypes and their stages.
- To confirm the distinct nature of AC and SCC through subtype-specific analyses.
Main Methods:
- Applied SAMGSR to a NSCLC gene expression dataset for feature selection.
- Compared SAMGSR performance against novel algorithms like LASSO.
- Utilized SAMGSR for subtype-specific analyses to differentiate stages (I vs. II) within AC and SCC.
Main Results:
- SAMGSR demonstrated equivalent or superior performance to LASSO in predictive ability and model parsimony.
- Gene signatures derived from SAMGSR effectively distinguished AC and SCC subtypes.
- Minimal overlap between AC and SCC gene signatures further supports their distinct biological identities.
Conclusions:
- SAMGSR is a validated feature selection algorithm suitable for constructing gene expression signatures.
- The distinct gene signatures for AC and SCC underscore the need for subtype-specific diagnostic and prognostic signature development.
- Stratified analyses are recommended for constructing accurate diagnostic or prognostic signatures for NSCLC subtypes.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019